TLDR A rare genetic mutation causes severe immune issues, hair loss, and nail problems.
The document discussed the nude phenotype, a severe form of combined immunodeficiency (SCID) characterized by T cell immunodeficiency, congenital alopecia, and nail dystrophy. This condition was first identified in humans in 1996, following its initial description in mice in 1966. The genetic mutation responsible was identified in 1994 as a mutation in the Foxn1 gene. The condition is extremely rare, with an incidence of less than 1 in 1,000,000, and leads to severe infections early in life due to profound T cell impairment. Patients also exhibit skin and hair abnormalities.
33 citations
,
September 2017 in “Journal of clinical immunology” New treatments for immune disorders caused by FOXN1 deficiency are promising.
17 citations
,
June 2017 in “Gene” A rare genetic mutation found in an Indian family can be detected through prenatal screening.
103 citations
,
January 2011 in “Blood” Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.
32 citations
,
January 2017 in “Orphanet journal of rare diseases” FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.
November 2020 in “International journal of contemporary pediatrics” Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.
1 citations
,
February 2013 in “InTech eBooks” Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.
17 citations
,
June 2017 in “Gene” A rare genetic mutation found in an Indian family can be detected through prenatal screening.
86 citations
,
October 2005 in “Experimental Dermatology” The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.
89 citations
,
September 2010 in “Annual Review of Genomics and Human Genetics” The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.
